Cochlear

Cochlear EBIT Margin

The EBIT Margin (Operating Margin) of Cochlear (COH.AX) as of Oct 18, 2026 is 12.89 %. In the previous year, EBIT Margin (Operating Margin) was 17.33 % — a change of -25.61% (lower).

EBIT Margin

12.89 %

YoY

-25.61%

Last updated:

EBIT Margin (Operating Margin) of Cochlear is 2026 12.89 % . EBIT Margin (Operating Margin) of Cochlear was 2025 17.33 % . It decreases by -25.61% lower compared to the previous year.

For Cochlear, the operating (EBIT) margin of 12.9% is down versus 22.4% a few years ago.

The Cochlear EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
25.05 AUD
Jan 1, 2020
19.15 AUD
Jan 1, 2021
22.52 AUD
Jan 1, 2022
22.42 AUD
Jan 1, 2023
20.12 AUD
Jan 1, 2024
23.33 AUD
Jan 1, 2025
17.33 AUD
Jan 1, 2026
12.89 AUD
The Cochlear EBIT Margin history
YEAREBIT MarginYoY
12.89 %-25.61%
17.33 %-25.70%
23.33 %+15.95%
20.12 %-10.26%
22.42 %-0.46%
22.52 %+17.59%
19.15 %-23.55%
25.05 %-1.04%
25.31 %+0.69%
25.14 %+8.38%
23.20 %+4.62%
22.17 %+16.84%
18.98 %+8,552.90%
0.22 %+34.76%
0.16 %-44.87%
0.30 %+0.23%
0.29 %+17.54%
0.25 %+5.59%
0.24 %-3.25%
0.25 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

EBIT Margin (Operating Margin) of Cochlear is 12.89 % in 2026.

EBIT Margin (Operating Margin) of Cochlear changed from 17.33 % to 12.89 %, representing a -25.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Cochlear since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Cochlear with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Cochlear

All Key Metrics — Cochlear